- Home
- JAZZ vs EDU Comparison
JAZZ vs EDU Comparison
Compare JAZZ & EDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- EDU
- Stock Information
- Founded
- JAZZ 2003
- EDU 1993
- Country
- JAZZ Ireland
- EDU China
- Employees
- JAZZ N/A
- EDU N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- EDU Other Consumer Services
- Sector
- JAZZ Health Care
- EDU Real Estate
- Exchange
- JAZZ Nasdaq
- EDU Nasdaq
- Market Cap
- JAZZ 7.9B
- EDU 8.5B
- IPO Year
- JAZZ 2007
- EDU 2006
- Fundamental
- Price
- JAZZ $136.58
- EDU $51.94
- Analyst Decision
- JAZZ Strong Buy
- EDU Buy
- Analyst Count
- JAZZ 14
- EDU 6
- Target Price
- JAZZ $179.21
- EDU $56.87
- AVG Volume (30 Days)
- JAZZ 758.5K
- EDU 948.0K
- Earning Date
- JAZZ 11-05-2025
- EDU 10-28-2025
- Dividend Yield
- JAZZ N/A
- EDU N/A
- EPS Growth
- JAZZ N/A
- EDU 27.50
- EPS
- JAZZ N/A
- EDU 2.29
- Revenue
- JAZZ $4,086,695,000.00
- EDU $4,900,262,000.00
- Revenue This Year
- JAZZ $5.70
- EDU $9.22
- Revenue Next Year
- JAZZ $6.16
- EDU $10.00
- P/E Ratio
- JAZZ N/A
- EDU $22.99
- Revenue Growth
- JAZZ 4.52
- EDU 13.60
- 52 Week Low
- JAZZ $95.49
- EDU $40.66
- 52 Week High
- JAZZ $148.06
- EDU $82.68
- Technical
- Relative Strength Index (RSI)
- JAZZ 63.56
- EDU 54.81
- Support Level
- JAZZ $125.79
- EDU $52.08
- Resistance Level
- JAZZ $140.39
- EDU $54.65
- Average True Range (ATR)
- JAZZ 3.18
- EDU 1.35
- MACD
- JAZZ 0.46
- EDU -0.10
- Stochastic Oscillator
- JAZZ 71.59
- EDU 34.15
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About EDU New Oriental Education & Technology Group Inc.
New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.